HomeNewsBusinessAnnouncementsGlenmark Pharma gets ANDA approval for Clotrimazole and Betamethasone Dipropionate cream

Glenmark Pharma gets ANDA approval for Clotrimazole and Betamethasone Dipropionate cream

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the USFDA for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%.

November 09, 2015 / 09:41 IST

Story continues below Advertisement

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 09, 2015 titled "Glenmark Pharmaceuticals receives ANDA approval for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%".Source : BSE

Read all announcements in Glenmark

first published: Nov 9, 2015 09:41 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glenmark Pharma gets ANDA approval for Clotrimazole and Betamethasone Dipropionate cream

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the USFDA for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links